40 results
424B3
BTTX
Better Therapeutics Inc
28 Dec 23
Prospectus supplement
9:23pm
and voting rights, without stockholder approval, which could be used to significantly dilute the ownership of a hostile acquirer;
the limitation … securities or securities convertible into equity may dilute the economic and voting rights of our existing stockholders or reduce the market price of our
PRE 14A
08skgkouysqi6tc
6 Oct 23
Preliminary proxy
4:15pm
424B5
hu27fu1ilvpf8k2v
9 Aug 23
Prospectus supplement for primary offering
4:37pm
424B5
4bee ilt72ecfegzfw5y
26 Jul 23
Prospectus supplement for primary offering
5:04pm
424B5
3bumfwdt
11 May 23
Prospectus supplement for primary offering
5:20pm
S-3
e6d09kvt
17 Apr 23
Shelf registration
5:48pm
POS AM
x75fuwob
30 Mar 23
Prospectus update (post-effective amendment)
7:15pm